155 related articles for article (PubMed ID: 25095502)
1. Statins in heart transplantation.
Kittleson MM; Kobashigawa JA
Clin Transpl; 2013; ():135-43. PubMed ID: 25095502
[TBL] [Abstract][Full Text] [Related]
2. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
[TBL] [Abstract][Full Text] [Related]
3. Statins and cardiac allograft vasculopathy after heart transplantation.
Kobashigawa JA
Semin Vasc Med; 2004 Nov; 4(4):401-6. PubMed ID: 15861321
[TBL] [Abstract][Full Text] [Related]
4. Statin therapy is not associated with improved outcomes after heart transplantation in children and adolescents.
Greenway SC; Butts R; Naftel DC; Pruitt E; Kirklin JK; Larsen I; Urschel S; Knecht K; Law Y
J Heart Lung Transplant; 2016 Apr; 35(4):457-65. PubMed ID: 26746989
[TBL] [Abstract][Full Text] [Related]
5. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
[TBL] [Abstract][Full Text] [Related]
6. Statins and the risk of cancer after heart transplantation.
Fröhlich GM; Rufibach K; Enseleit F; Wolfrum M; von Babo M; Frank M; Berli R; Hermann M; Holzmeister J; Wilhelm M; Falk V; Noll G; Lüscher TF; Ruschitzka F
Circulation; 2012 Jul; 126(4):440-7. PubMed ID: 22761452
[TBL] [Abstract][Full Text] [Related]
7. Metaanalysis of statins and survival in de novo cardiac transplantation.
Mehra MR; Raval NY
Transplant Proc; 2004 Jun; 36(5):1539-41. PubMed ID: 15251380
[TBL] [Abstract][Full Text] [Related]
8. Impact of Statin Use After Heart Transplantation: A Meta-Analysis.
Vallakati A; Reddy S; Dunlap ME; Taylor DO
Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27729391
[TBL] [Abstract][Full Text] [Related]
9. Acute renal allograft rejections, a role for statins?
Holdaas H; Jardine A
Minerva Urol Nefrol; 2003 Jun; 55(2):111-9. PubMed ID: 12847415
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hyperlipidemia in cardiac transplant recipients.
Bilchick KC; Henrikson CA; Skojec D; Kasper EK; Blumenthal RS
Am Heart J; 2004 Aug; 148(2):200-10. PubMed ID: 15308989
[TBL] [Abstract][Full Text] [Related]
11. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.
Kobashigawa JA; Moriguchi JD; Laks H; Wener L; Hage A; Hamilton MA; Cogert G; Marquez A; Vassilakis ME; Patel J; Yeatman L
J Heart Lung Transplant; 2005 Nov; 24(11):1736-40. PubMed ID: 16297773
[TBL] [Abstract][Full Text] [Related]
12. Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry.
Wu AH; Ballantyne CM; Short BC; Torre-Amione G; Young JB; Ventura HO; Eisen HJ; Radovancevic B; Rayburn BK; Lake KD; Yancy CW; Taylor DO; Mehra MR; Kubo SH; Fishbein DP; Zhao XQ; O'Brien KD
Am J Cardiol; 2005 Feb; 95(3):367-72. PubMed ID: 15670546
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
[TBL] [Abstract][Full Text] [Related]
15. Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality.
Roussel JC; Baron O; Périgaud C; Bizouarn P; Pattier S; Habash O; Mugniot A; Petit T; Michaud JL; Heymann MF; Treilhaud M; Trochu JN; Gueffet JP; Lamirault G; Duveau D; Despins P
J Heart Lung Transplant; 2008 May; 27(5):486-93. PubMed ID: 18442713
[TBL] [Abstract][Full Text] [Related]
16. Dual roles of HMG-CoA reductase inhibitors in solid organ transplantation: lipid lowering and immunosuppression.
Katznelson S; Kobashigawa JA
Kidney Int Suppl; 1995 Dec; 52():S112-5. PubMed ID: 8587272
[TBL] [Abstract][Full Text] [Related]
17. Applications of statins in cardiothoracic surgery: more than just lipid-lowering.
Paraskevas KI
Eur J Cardiothorac Surg; 2008 Mar; 33(3):377-90. PubMed ID: 18248999
[TBL] [Abstract][Full Text] [Related]
18. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation.
Mahle WT; Vincent RN; Berg AM; Kanter KR
J Heart Lung Transplant; 2005 Jan; 24(1):63-6. PubMed ID: 15653381
[TBL] [Abstract][Full Text] [Related]
19. Statins in solid organ transplantation: is there an immunosuppressive effect?
Kobashigawa JA
Am J Transplant; 2004 Jul; 4(7):1013-8. PubMed ID: 15196056
[TBL] [Abstract][Full Text] [Related]
20. Can the potential benefits of statins in general medical practice be extrapolated to liver transplantation?
Neal DA; Alexander GJ
Liver Transpl; 2001 Dec; 7(12):1009-14. PubMed ID: 11753902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
